Publication | Closed Access

Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-α inhibitory activity

Molecular DockingMolecular PharmacologyMedicinal ChemistryNew Pyrazole-thiazolidinonesAnti-inflammatoryMedicineDrug DiscoveryPharmacological AgentPharmacotherapyDrug DevelopmentPharmacologyTnf-α Inhibitory ActivityBiomolecular Engineering